JAGX
Jaguar Animal Health IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.09M
P/E Ratio
—
EPS
$-2.58
Beta
0.29
52W High
$15.48
52W Low
$0.31
50-Day MA
$0.58
200-Day MA
$1.52
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
200.00
PEG Ratio
-0.02
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset, specifically chronic debilitating diarrhea. The company is headquartered in San Francisco, California.
Fundamentals
| Revenue (TTM) | $11.79M |
| Gross Profit (TTM) | $9.65M |
| EBITDA | $-30.91M |
| Operating Margin | -234.80% |
| Return on Equity | -411.60% |
| Return on Assets | -38.00% |
| Revenue/Share (TTM) | $10.16 |
| Book Value | $0.85 |
| Price-to-Book | 1.59 |
| Price-to-Sales (TTM) | 0.43 |
| EV/Revenue | 3.042 |
| EV/EBITDA | -0.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -0.80% |
| Shares Outstanding | $12.42M |
| Float | $3.46M |
| % Insiders | 11.48% |
| % Institutions | 0.53% |
Data last updated: 4/8/2026